Coloplast A/S (CO:COLO-B) — Market Cap & Net Worth
Market Cap & Net Worth: Coloplast A/S (COLO-B)
Coloplast A/S (CO:COLO-B) has a market capitalization of $12.42 Billion (Dkr79.40 Billion) as of June 15, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #1903 globally and #12 in its home market, demonstrating a 1.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Coloplast A/S's stock price Dkr382.90 by its total outstanding shares 207366796 (207.37 Million). Review COLO-B total liabilities to assess the company's total debt and financial obligations.
Coloplast A/S Market Cap History: 2015 to 2026
Coloplast A/S's market capitalization history from 2015 to 2026. Data shows change from $14.78 Billion to $12.42 Billion (-0.03% CAGR).
Index Memberships
Coloplast A/S is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
STOXX Europe Large 200 EUR Price
LCXP
|
$7.18 Trillion | 0.17% | #100 of 182 |
|
STOXX Europe Large 200 Net Return
LCXR
|
$7.18 Trillion | 0.17% | #100 of 182 |
Weight: Coloplast A/S's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Coloplast A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Coloplast A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.64x
Coloplast A/S's market cap is 0.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.88x
Coloplast A/S's market cap is 4.88 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.02 Billion | $14.68 Billion | $3.14 Billion | 0.89x | 4.14x |
| 2017 | $13.90 Billion | $15.53 Billion | $3.80 Billion | 0.89x | 3.66x |
| 2018 | $17.50 Billion | $16.45 Billion | $3.85 Billion | 1.06x | 4.55x |
| 2019 | $24.43 Billion | $17.94 Billion | $3.87 Billion | 1.36x | 6.31x |
| 2020 | $28.02 Billion | $18.54 Billion | $4.20 Billion | 1.51x | 6.68x |
| 2021 | $35.33 Billion | $19.43 Billion | $4.83 Billion | 1.82x | 7.32x |
| 2022 | $25.51 Billion | $22.58 Billion | $4.71 Billion | 1.13x | 5.42x |
| 2023 | $24.90 Billion | $24.50 Billion | $4.78 Billion | 1.02x | 5.21x |
| 2024 | $25.51 Billion | $27.03 Billion | $5.05 Billion | 0.94x | 5.05x |
| 2025 | $17.73 Billion | $27.87 Billion | $3.64 Billion | 0.64x | 4.88x |
Competitor Companies of COLO-B by Market Capitalization
Companies near Coloplast A/S in the global market cap rankings as of June 15, 2026.
Key companies related to Coloplast A/S by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #162 globally with a market cap of $145.58 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $98.90 Billion USD ( €84.60 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #344 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #537 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Intuitive Surgical Inc | NASDAQ:ISRG | $145.58 Billion | $411.06 |
| #258 | EssilorLuxottica S. A. | PA:EL | $98.90 Billion | €182.70 |
| #344 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €90.00 |
| #537 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Coloplast A/S Historical Marketcap From 2015 to 2026
Between 2015 and today, Coloplast A/S's market cap moved from $14.78 Billion to $ 12.42 Billion, with a yearly change of -0.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr12.42 Billion | -29.92% |
| 2025 | Dkr17.73 Billion | -30.50% |
| 2024 | Dkr25.51 Billion | +2.45% |
| 2023 | Dkr24.90 Billion | -2.40% |
| 2022 | Dkr25.51 Billion | -27.80% |
| 2021 | Dkr35.33 Billion | +26.10% |
| 2020 | Dkr28.02 Billion | +14.68% |
| 2019 | Dkr24.43 Billion | +39.66% |
| 2018 | Dkr17.50 Billion | +25.89% |
| 2017 | Dkr13.90 Billion | +6.74% |
| 2016 | Dkr13.02 Billion | -11.93% |
| 2015 | Dkr14.78 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 15th, 2026 the market cap of Coloplast A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.42 Billion USD |
| MoneyControl | $12.42 Billion USD |
| MarketWatch | $12.42 Billion USD |
| marketcap.company | $12.42 Billion USD |
| Reuters | $12.42 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more